Generic Budesonide Formoterol Rotacaps

Budesonide + Formoterol Rotacaps are used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). Budesonide is a corticosteroid that reduces airway inflammation, while formoterol is a long-acting bronchodilator that relaxes the muscles around the airways to improve breathing. Together, they help to prevent wheezing, shortness of breath, and flare-ups. This combination is for regular maintenance treatment, not for acute asthma attacks.

Dosage and direction

The usual adult dose is one rotacap twice daily, inhaled using a Rotahaler device, but the exact dose is determined by the physician based on the patient’s condition. Capsules should never be swallowed; they must be inhaled properly through the device. It’s important to use the medication at the same times each day for optimal effect. Rinse the mouth after inhalation to help prevent oral thrush.

Precautions

Patients should be monitored for signs of oral infections, bone loss, and vision changes. Use with caution in individuals with heart problems, hypertension, thyroid disorders, or diabetes. The medication should not be used for sudden breathing problems—a rescue inhaler should be kept available. Do not discontinue the drug abruptly without consulting a healthcare provider.

Contraindications

This combination should not be used by individuals with a known hypersensitivity to budesonide, formoterol, or any capsule ingredients. It is not recommended during pregnancy or breastfeeding unless clearly needed and prescribed. Patients with active tuberculosis, untreated fungal or viral respiratory infections, or acute asthma episodes should not use this medication. Not suitable for children unless advised by a pediatrician.

Possible side effect

Common side effects include throat irritation, cough, headache, nausea, and tremors. Some users may experience palpitations, sleep disturbances, or oral thrush (candidiasis). Rare but serious side effects include paradoxical bronchospasm, high blood pressure, or adrenal suppression. Contact your doctor if you experience worsening breathing, chest pain, or vision problems.

Drug interaction

Budesonide-formoterol may interact with beta-blockers, diuretics, MAO inhibitors, and CYP3A4 inhibitors like ketoconazole. Using it with other inhaled bronchodilators or corticosteroids may increase the risk of side effects. Always inform your doctor about all medications and herbal products you are taking. Avoid grapefruit juice, which can affect budesonide metabolism.

Missed dose

If you miss a dose, take it as soon as you remember. If it’s almost time for your next scheduled dose, skip the missed one and continue with your regular schedule. Do not take a double dose to make up for the missed one. Missing doses can reduce treatment effectiveness, so try to maintain consistency.

Overdose

Symptoms of overdose may include nervousness, rapid heartbeat, tremors, or headache. Excessive use of formoterol can lead to serious heart problems or electrolyte imbalance. In case of overdose, seek immediate medical attention. Supportive care is typically required, and hospitalization may be necessary in severe cases.

Storage

Store rotacaps in a cool, dry place at room temperature (20–25°C / 68–77°F), away from moisture and direct sunlight. Keep them in their blister packaging until ready to use. Do not use damaged or expired rotacaps. Keep out of reach of children.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.

Clinical Verification

Last Clinically Updated: August 15, 2026

Written By

Dr. Elena Vance, PharmD

Clinical Specialist in Neuropharmacology

Fact Checked By

Marcus Thorne, MS

Biomedical Data & FDA Label Verification

Medically Reviewed By

Dr. Arthur Campbell, MD

Board-Certified Psychiatrist (ABPN)